Uzma Shah

ORCID: 0000-0003-0671-0639
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Pancreatitis Pathology and Treatment
  • Pediatric Hepatobiliary Diseases and Treatments
  • Liver Disease Diagnosis and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Liver Diseases and Immunity
  • Gallbladder and Bile Duct Disorders
  • Cystic Fibrosis Research Advances
  • Liver Disease and Transplantation
  • Childhood Cancer Survivors' Quality of Life
  • Inflammatory Bowel Disease
  • Gastrointestinal disorders and treatments
  • IgG4-Related and Inflammatory Diseases
  • Hepatitis Viruses Studies and Epidemiology
  • Diabetes and associated disorders
  • Child Nutrition and Water Access
  • Hepatitis B Virus Studies
  • Infant Nutrition and Health
  • Hepatitis C virus research
  • Neonatal Respiratory Health Research
  • Neuroendocrine Tumor Research Advances
  • Digestive system and related health
  • Prostate Cancer Treatment and Research
  • Monoclonal and Polyclonal Antibodies Research
  • Connexins and lens biology
  • Amoebic Infections and Treatments

Massachusetts General Hospital
2013-2024

MaineGeneral Medical Center
2011-2024

Henry Ford Health System
2024

Harvard University
2012-2023

The University of Texas MD Anderson Cancer Center
2022

Primary Children's Hospital
2020

University of Utah
2020

Stanford University
2019

Harvard University Press
2018-2019

University of Minnesota Children's Hospital
2018

Background and Aims Many children with primary sclerosing cholangitis (PSC) receive oral vancomycin therapy (OVT) or ursodeoxycholic acid (UDCA). There is a paucity of data on whether these medications improve outcomes. Approach Results We analyzed retrospective from the Pediatric PSC Consortium. Children treated OVT were matched 1:1:1 to those UDCA managed observation (no treatment) based closest propensity score, ensuring similar baseline characteristics. Two hundred sixty‐four patients...

10.1002/hep.31560 article EN Hepatology 2020-09-18
Shannon M. Vandriel Liting Li Huiyu She Jian‐She Wang Melissa A. Gilbert and 88 more Irena Jankowska Piotr Czubkowski Dorota Gliwicz‐Miedzińska Emmanuel Gonzalès Emmanuel Jacquemin Jérôme Bouligand Nancy B. Spinner Kathleen M. Loomes David A. Piccoli Lorenzo D’Antiga Emanuele Nicastro Étienne Sokal Tanguy Demaret Noelle H. Ebel Jeffrey A. Feinstein Rima Fawaz Silvia Nastasio Florence Lacaille Dominique Debray Henrik Arnell Björn Fischler Susan Siew Michael Stormon Saul J. Karpen René Romero Kyung Mo Kim Woo Yim Baek Winita Hardikar Sahana Shankar Amin J. Roberts Helen Evans M. Kyle Jensen Marianne Kavan Shikha S. Sundaram Alexander Chaidez Palaniswamy Karthikeyan María Camila Sanchez Maria Lorena Cavalieri Henkjan J. Verkade Way Seah Lee James E. Squires Christina Hajinicolaou Chatmanee Lertudomphonwanit Ryan T. Fischer Catherine Larson‐Nath Yael Mozer‐Glassberg Çiğdem Arıkan Henry C. Lin Jesús Quintero Seema Alam Déirdre Kelly Elisa de Carvalho Cristina Targa Ferreira Giuseppe Indolfi Rubén E. Quirós‐Tejeira Pinar Bulut Pier Luigi Calvo Zerrin Önal Pamela L. Valentino Dev M. Desai John Eshun Maria Rogalidou Antal Dezsöfi Sabina Więcek Gabriella Nebbia Raquel Borges Pinto Victorien M. Wolters María Legarda Tamara Andréanne N. Zizzo Jennifer García Kathleen B. Schwarz Marisa Beretta Thomas Damgaard Sandahl Carolina Jiménez‐Rivera Nanda Kerkar Jernej Brecelj Quais Mujawar Nathalie Rock Cristina Molera Busoms Wikrom Karnsakul Eberhard Lurz Ermelinda Santos Silva Niviann Blondet Luís Bujanda Uzma Shah Richard J. Thompson Bettina E. Hansen Binita M. Kamath

Background and Aims: Alagille syndrome (ALGS) is a multisystem disorder, characterized by cholestasis. Existing outcome data are largely derived from tertiary centers, real‐world lacking. This study aimed to elucidate the natural history of liver disease in contemporary, international cohort children with ALGS. Approach Results: was multicenter retrospective clinically and/or genetically confirmed ALGS diagnosis, born between January 1997 August 2019. Native survival (NLS) event‐free rates...

10.1002/hep.32761 article EN cc-by-nc Hepatology 2022-08-29

Summary Background Data on oral vancomycin for primary sclerosing cholangitis (PSC)‐associated inflammatory bowel disease (IBD) are limited. Aims Using data from the Paediatric PSC Consortium, to examine effect of IBD activity. Methods In this retrospective multi‐centre cohort study, we matched vancomycin‐treated and untreated patients (1:3) based duration at time outcome assessment. The was Physician Global Assessment (PGA) clinical activity after 1 year (±6 months) vancomycin. We used...

10.1111/apt.17936 article EN Alimentary Pharmacology & Therapeutics 2024-03-10

We explored pancreatic neuroendocrine tumors (PanNETs) associated with tuberous sclerosis complex (TSC) to determine their incidence in the TSC population; define clinical, radiological, and pathological characteristics; investigate association underlying genotypes. Retrospectively reviewed abdominal imaging of 219 patients TSC, evaluating incidence, size, architecture lesions. Pathology records at Massachusetts General Hospital (MGH) were for all PanNET diagnoses TSC. Literature was...

10.1111/j.1399-0004.2011.01805.x article EN Clinical Genetics 2011-10-28

ABSTRACT Objectives: The aim of the present study was to investigate natural history chronic pancreatitis (CP); patients in North American Pancreatitis Study2 (NAPS2, adults) and INternational Study group Pediatric Pancreatitis: In search for a cuRE (INSPPIRE, pediatric) were compared. Methods: Demographics, risk factors, disease duration, management outcomes 224 children 1063 adults compared using appropriate statistical tests categorical continuous variables. Results: Alcohol 53% 1% ( P...

10.1097/mpg.0000000000002279 article EN publisher-specific-oa Journal of Pediatric Gastroenterology and Nutrition 2019-02-02
Bettina E. Hansen Shannon M. Vandriel Pamela Vig Will Garner Douglas Mogul and 90 more Kathleen M. Loomes David A. Piccoli Elizabeth B. Rand Irena Jankowska Piotr Czubkowski Dorota Gliwicz‐Miedzińska Emmanuel Gonzalès Emmanuel Jacquemin Jérôme Bouligand Lorenzo D’Antiga Emanuele Nicastro Henrik Arnell Björn Fischler Étienne Sokal Tanguy Demaret Susan Siew Michael Stormon Saul J. Karpen René Romero Noelle H. Ebel Jeffrey A. Feinstein Amin J. Roberts Helen Evans Shikha S. Sundaram Alexander Chaidez Winita Hardikar Sahana Shankar Ryan T. Fischer Florence Lacaille Dominique Debray Henry C. Lin M. Kyle Jensen Catalina Jaramillo Palaniswamy Karthikeyan Giuseppe Indolfi Henkjan J. Verkade Catherine Larson‐Nath Rubén E. Quirós‐Tejeira Pamela L. Valentino Maria Rogalidou Antal Dezsöfi James E. Squires Kathleen B. Schwarz Pier Luigi Calvo Jesús Quintero Andréanne N. Zizzo Gabriella Nebbia Pinar Bulut Ermelinda Santos Silva Rima Fawaz Silvia Nastasio Wikrom Karnsakul María Legarda Tamara Cristina Molera Busoms Déirdre Kelly Thomas Damgaard Sandahl Carolina Jiménez‐Rivera Jesús M. Bañales Quais Mujawar Liting Li Huiyu She Jian‐She Wang Kyung Mo Kim Seak Hee Oh María Camila Sanchez Maria Lorena Cavalieri Way Seah Lee Christina Hajinicolaou Chatmanee Lertudomphonwanit Orith Waisbourd‐Zinman Çiğdem Arıkan Seema Alam Elisa de Carvalho Melina U. Melere John Eshun Zerrin Önal Dev M. Desai Sabina Więcek Raquel Borges Pinto Victorien M. Wolters Jennifer García Marisa Beretta Nanda Kerkar Jernej Brecelj Nathalie Rock Eberhard Lurz Niviann Blondet Uzma Shah Richard J. Thompson Binita M. Kamath

Background and Aims: Alagille syndrome (ALGS) is characterized by chronic cholestasis with associated pruritus extrahepatic anomalies. Maralixibat, an ileal bile acid transporter inhibitor, approved pharmacologic therapy for cholestatic in ALGS. Since long-term placebo-controlled studies are not feasible or ethical children rare diseases, a novel approach was taken comparing 6-year outcomes from maralixibat trials aligned harmonized natural history cohort the G lobal AL agille A lliance...

10.1097/hep.0000000000000727 article EN cc-by-nc-nd Hepatology 2023-12-25

The aim of the study was to determine rate progression from acute recurrent pancreatitis (ARP) chronic (CP) in children and assess risk factors.Data were collected INternational Study group Pediatric Pancreatitis: In search for a cuRE (INSPPIRE) cohort. Kaplan-Meier curves constructed calculate duration initial attack (AP) CP. Log-rank test used compare survival (nonprogression) probability distribution between groups. Cox proportional hazard regression models fitted obtain ratio (with 95%...

10.1097/mpg.0000000000002405 article EN Journal of Pediatric Gastroenterology and Nutrition 2019-05-27

The significance of pancreas divisum (PD) as a risk factor for pancreatitis is controversial. We analyzed the characteristics children with PD associated acute recurrent or chronic to better understand its impact.We compared without in well-phenotyped INSPPIRE (INternational Study group Pediatric Pancreatitis: In search cuRE) cohort. Differences were using 2-sample t test Wilcoxon rank sum continuous variables, Pearson χ Fisher exact categorical variables.PD was found 52 359 (14.5%)...

10.1097/mcg.0000000000001063 article EN Journal of Clinical Gastroenterology 2018-06-04

Autoimmune pancreatitis (AIP) represents a complex immune-mediated pancreas disorder. Pediatric AIP (P-AIP) is rare. We have recently summarized the characteristic features of P-AIP. now aim to develop recommendation statements standardize diagnostic and therapeutic approach P-AIP facilitate future research in field.A panel pediatric gastroenterologists participating International Study Group Pancreatitis: In search for cuRE was formed discuss then vote on 15 statements. A consensus at least...

10.1097/mpg.0000000000002028 article EN Journal of Pediatric Gastroenterology and Nutrition 2018-05-10

We created the INternational Study Group of Pediatric Pancreatitis: In Search for a CuRE (INSPPIRE 2) cohort to study risk factors, natural history, and outcomes pediatric acute recurrent pancreatitis chronic (CP). Patient physician questionnaires collect information on demographics, clinical family social disease outcomes. Health-related quality life, depression, anxiety are measured using validated questionnaires. Information entered paper is transferred into database managed by Consortium...

10.1097/mpa.0000000000001172 article EN Pancreas 2018-10-16

In young children hepatitis A virus (HAV) infections are usually subclinical events. However, HAV is also associated with progressive hepatic failure and even death in some patients. This study was undertaken to characterize the course of A-related acute liver from a developing country where endemic produces significant morbidity. Patients <15 years age confirmed A, seen at Aga Khan University Hospital between January 1991 August 1998 were identified using patient registry. Of 2735...

10.1542/peds.105.2.436 article EN PEDIATRICS 2000-02-01

Abstract Introduction The objective of this study was to evaluate the feasibility shear wave elastography ( SWE ), as a non‐invasive means assessing liver fibrosis stage in paediatric and adolescent patients. Materials Methods Consecutive subjects scheduled for biopsy LB ) evaluation known or suspected diffuse disease were included after informed guardian consent subject assent IRB ‐approved single institution study. Elastograms acquired prior biopsy, from under breath‐hold normal...

10.1111/1754-9485.12388 article EN Journal of Medical Imaging and Radiation Oncology 2015-10-27

Adults with chronic pancreatitis (CP) have a high risk for developing pancreatogenic diabetes mellitus (DM), but little is known regarding potential factors DM in children acute recurrent (ARP) or CP. We compared demographic and clinical features of ARP CP, without DM, the INternational Study Group Pediatric Pancreatitis: In Search CuRE (INSPPIRE) registry.We reviewed INSPPIRE database presence absence physician-diagnosed 397 children, excluding those total pancreatectomy islet...

10.1097/mpg.0000000000002482 article EN publisher-specific-oa Journal of Pediatric Gastroenterology and Nutrition 2019-08-28

Primary intestinal lymphangiectasia (PIL) is a rare protein‐losing enteropathy characterized by congenital malformation of the lymphatic vessels small intestine causing insufficient drainage and leakage lymph fluid. Tuberous sclerosis complex (TSC) an autosomal dominant genetic disorder benign hamartomas in multiple organ systems. While system has been implicated TSC through lymphangioleiomyomatosis (LAM) lymphedema, this paper reports first case PIL TSC, female patient with TSC2 mutation....

10.1002/ajmg.a.37148 article EN American Journal of Medical Genetics Part A 2015-05-05
Coming Soon ...